Flagellin enhances saliva IgA response and protection of anti-caries DNA vaccine.
We and others have shown that anti-caries DNA vaccines, including pGJA-P/VAX, are promising for preventing dental caries. However, challenges remain because of the low immunogenicity of DNA vaccines. In this study, we used recombinant flagellin protein derived from Salmonella (FliC) as a mucosal adjuvant for anti-caries DNA vaccine (pGJA-P/VAX) and analyzed the effects of FliC protein on the serum PAc-specific IgG and saliva PAc-specific IgA antibody responses, the colonization of Streptococcus mutans (S. mutans) on rat teeth, and the formation of caries lesions. Our results showed that FliC promoted the production of PAc-specific IgG in serum and secretory IgA (S-IgA) in saliva of rats by intranasal immunization with pGJA-P/VAX plus FliC. Furthermore, we found that enhanced PAc-specific IgA responses in saliva were associated with the inhibition of S. mutans colonization of tooth surfaces and endowed better protection with significant fewer caries lesions. In conclusion, our study demonstrates that recombinant FliC could enhance specific IgA responses in saliva and protective ability of pGJA-P/VAX, providing an effective mucosal adjuvant candidate for intranasal immunization of an anti-caries DNA vaccine.
Mucosal Immunity Research Group, State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.
W
W
Shi
Y H
YH
Li
F
F
Liu
J Y
JY
Yang
D H
DH
Zhou
Y Q
YQ
Chen
Y
Y
Zhang
Y
Y
Yang
B X
BX
He
C
C
Han
M W
MW
Fan
H M
HM
Yan
D000276:Adjuvants, Immunologic; D000281:Administration, Intranasal; D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology; D003731:Dental Caries / Q000517:prevention & control*; D005260:Female; D005408:Flagellin / Q000276:immunology*; D007071:Immunoglobulin A, Secretory / Q000276:immunology; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins / Q000276:immunology; D012471:Salivary Proteins and Peptides / Q000276:immunology; D012475:Salmonella / Q000276:immunology; D013295:Streptococcus mutans / Q000276:immunology*; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000276:immunology*; D037521:Virulence Factors
D000276:Adjuvants, Immunologic; D000907:Antibodies, Bacterial; D007071:Immunoglobulin A, Secretory; D011994:Recombinant Proteins; D012471:Salivary Proteins and Peptides; D019444:Vaccines, DNA; D037521:Virulence Factors; C530535:pGJA-P VAX vaccine; D005408:Flagellin